6-111310079-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2

The NM_001372078.1(REV3L):​c.8816G>A​(p.Arg2939Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000475 in 1,557,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000048 ( 0 hom. )

Consequence

REV3L
NM_001372078.1 missense

Scores

4
2
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.69
Variant links:
Genes affected
REV3L (HGNC:9968): (REV3 like, DNA directed polymerase zeta catalytic subunit) The protein encoded by this gene represents the catalytic subunit of DNA polymerase zeta, which functions in translesion DNA synthesis. The encoded protein can be found in mitochondria, where it protects DNA from damage. Defects in this gene are a cause of Mobius syndrome. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), REV3L. . Gene score misZ 2.4677 (greater than the threshold 3.09). Trascript score misZ 3.98 (greater than threshold 3.09). GenCC has associacion of gene with Mobius syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.054683268).
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
REV3LNM_001372078.1 linkuse as main transcriptc.8816G>A p.Arg2939Gln missense_variant 30/32 ENST00000368802.8 NP_001359007.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
REV3LENST00000368802.8 linkuse as main transcriptc.8816G>A p.Arg2939Gln missense_variant 30/321 NM_001372078.1 ENSP00000357792.3 O60673-1

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151910
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000834
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000121
AC:
26
AN:
215234
Hom.:
0
AF XY:
0.000111
AC XY:
13
AN XY:
116664
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000614
Gnomad SAS exome
AF:
0.00107
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000484
AC:
68
AN:
1405434
Hom.:
0
Cov.:
30
AF XY:
0.0000489
AC XY:
34
AN XY:
695930
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000262
Gnomad4 SAS exome
AF:
0.000748
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000185
Gnomad4 OTH exome
AF:
0.000104
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
152028
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000835
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.000157
AC:
19
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 20, 2024The c.8816G>A (p.R2939Q) alteration is located in exon 30 (coding exon 30) of the REV3L gene. This alteration results from a G to A substitution at nucleotide position 8816, causing the arginine (R) at amino acid position 2939 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.40
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.095
T;T;.;T;.
Eigen
Uncertain
0.68
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.97
.;.;D;D;D
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.055
T;T;T;T;T
MetaSVM
Benign
-1.2
T
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.2
N;N;N;N;.
REVEL
Benign
0.21
Sift
Benign
0.081
T;T;T;T;.
Sift4G
Benign
0.28
T;T;T;T;T
Polyphen
1.0
D;D;.;D;.
Vest4
0.41
MutPred
0.57
Loss of phosphorylation at S2941 (P = 0.0692);Loss of phosphorylation at S2941 (P = 0.0692);.;Loss of phosphorylation at S2941 (P = 0.0692);.;
MVP
0.32
MPC
1.7
ClinPred
0.32
T
GERP RS
5.3
Varity_R
0.22
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs569959075; hg19: chr6-111631282; API